Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PG102P for Uremic Pruritus in Hemodialysis Patients
NCT03576235Completed
- Sponsor
- SMG-SNU Boramae Medical Center
- Start
- May 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of PG102P in uremic pruritus, sponsored by SMG-SNU Boramae Medical Center. Primary endpoint: Visual Analog Scale change from baseline at 10 weeks. Started May 2018; status: completed.
02
Drugs
PG102P
03
Conditions
uremic pruritus
Beyond the preview
Go deeper on NCT03576235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03576235.